These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2269476)

  • 1. Human intravenous immunoglobulin modulates monokine production in vitro.
    Andersson JP; Andersson UG
    Immunology; 1990 Nov; 71(3):372-6. PubMed ID: 2269476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human interleukin 6 and tumor necrosis factor alpha production studied at a single-cell level.
    Andersson U; Matsuda T
    Eur J Immunol; 1989 Jun; 19(6):1157-60. PubMed ID: 2526742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells.
    Wu KH; Wu WM; Lu MY; Chiang BL
    Pediatr Allergy Immunol; 2006 Feb; 17(1):60-8. PubMed ID: 16426257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.
    Andersson UG; Björk L; Skansén-Saphir U; Andersson JP
    Immunology; 1993 Jun; 79(2):211-6. PubMed ID: 8344700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG.
    Skansén-Saphir U; Andersson J; Björk L; Andersson U
    Eur J Immunol; 1994 Apr; 24(4):916-22. PubMed ID: 8149962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin).
    Ruiz de Souza V; Carreno MP; Kaveri SV; Ledur A; Sadeghi H; Cavaillon JM; Kazatchkine MD; Haeffner-Cavaillon N
    Eur J Immunol; 1995 May; 25(5):1267-73. PubMed ID: 7774630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.
    Schandené L; Vandenbussche P; Crusiaux A; Alègre ML; Abramowicz D; Dupont E; Content J; Goldman M
    Immunology; 1992 May; 76(1):30-4. PubMed ID: 1385797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of individual tumor necrosis factor/cachectin-producing cells after lipopolysaccharide induction.
    Henter JI; Söder O; Andersson U
    Eur J Immunol; 1988 Jul; 18(7):983-8. PubMed ID: 3042431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
    Daftarian PM; Kumar A; Kryworuchko M; Diaz-Mitoma F
    J Immunol; 1996 Jul; 157(1):12-20. PubMed ID: 8683105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha.
    Parry SL; Sebbag M; Feldmann M; Brennan FM
    J Immunol; 1997 Apr; 158(8):3673-81. PubMed ID: 9103430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4.
    Takashima T; Ohnishi K; Tsuyuguchi I; Kishimoto S
    J Immunol; 1993 Apr; 150(7):3002-10. PubMed ID: 8454870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the role of monokines in the generation of nonspecific suppressor T cell activity in vitro.
    Baxevanis CN; Dedousis GV; Gritzapis AD; Papadopoulos NG; Arsenis P; Katsiyiannis A; Papamichail M
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):225-45. PubMed ID: 8077608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors.
    Gessani S; Testa U; Varano B; Di Marzio P; Borghi P; Conti L; Barberi T; Tritarelli E; Martucci R; Seripa D
    J Immunol; 1993 Oct; 151(7):3758-66. PubMed ID: 7690813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented TNF-alpha and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes.
    Liese AM; Siddiqi MQ; Siegel JH; Denny T; Spolarics Z
    J Leukoc Biol; 2001 Aug; 70(2):289-96. PubMed ID: 11493622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early down-regulation of TNF production by LPS tolerance in human monocytes: comparison with IL-1 beta, IL-6, and IL-8.
    Mengozzi M; Fantuzzi G; Sironi M; Bianchi M; Fratelli M; Peri G; Bernasconi S; Ghezzi P
    Lymphokine Cytokine Res; 1993 Aug; 12(4):231-6. PubMed ID: 7692988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.